P2.16-20 Prognostic Utility of PET in Non-Small Cell Lung Cancer After Empiric Stereotactic Body Radiotherapy (SBRT)

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1495
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

FDG-PET Maximum Standardized Uptake Value Is Prognostic for Recurrence and Survival After Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2015English

Standardization of Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2015English

Salvage Lung Resection for Non-Small Cell Lung Cancer After Stereotactic Body Radiotherapy in Initially Operable Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Stereotactic Body Radiotherapy for Large (> 5 Cm) Non–Small-Cell Lung Cancer

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2017English

P3.08-02 Oligometastatic Non Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy (SBRT), a Single Institution Experience

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Feasibility of Stereotactic Body Radiotherapy for Locally-Advanced Non-Small Cell Lung Cancer

Clinical and Translational Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

CT Imaging Features Associated With Recurrence in Non-Small Cell Lung Cancer Patients After Stereotactic Body Radiotherapy

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Empiric Radiotherapy for Lung Cancer Collaborative Group Multi-Institutional Evidence-Based Guidelines for the Use of Empiric Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Without Pathologic Confirmation

Translational Lung Cancer Research
Oncology
2018English

(S038) Do Race or Income Influence Quality of Life (QOL) or Survival (OS) After Lung Stereotactic Body Radiotherapy (SBRT) in Stage I Non-Small Cell Lung Cancer? A Prospective Study

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy